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Purpose 
The development of effective treatments for age-related musculoskeletal diseases and the ability 
to predict disease progression has been hampered by the lack of substantive biomarkers able to 
demonstrate tissue pathology preceding identifiable tissue alterations. We have previously 
identified age-related dysregulation of a defined set of small nucleolar RNAs (snoRNAs) in 
cartilage and tendon ageing as well as the age-related disease osteoarthritis (OA). SnoRNAs are 
a class of evolutionary conserved non-coding small guide RNAs of which the majority directs the 
chemical modification of other RNA substrates, including ribosomal RNAs and spliceosomal 
RNAs. Profiling the expression patterns of snoRNAs in disease may help comprehend their 
functional significance in the development and progression of age-related musculoskeletal 
diseases, and provide diagnostic biomarkers and therapeutic targets. 
Methods 
C57BL6/J male mice were used for the study. RNA was isolated from joints and serum of old 
(n=6; 18 months old), young (n=6; 8 months old) and old OA (n=6 destabilisation of medial 
meniscus (DMM), n=3 sham; 24 months old) mice. Samples were submitted for library preparation 
using NEB small RNA library kit.  To reduce bias in our workflow we used tobacco acid 
pyrophosphatase to remove 5’CAP found on some snoRNAs. Samples were amplified for 15 
cycles, mixed into 3 pools, and size selected using a range 120-300bp. The size selected material 
was purified with Ampure beads.  Small RNA sequencing was undertaken on the Illumina HiSeq 
2000 platform using 100 base paired-end reads. The reference genome used for alignment was 
the mouse reference genome assembly GRCh38. The snoRNA count data were used to perform 
a data variation assessment. Differential expression analysis was conducted using edgeR. 
Significantly differentially expressed (DE) snoRNAs were defined with a FDR-adjusted P-
values<5%. Counts per million (CPM) were used to present expression values. 
 
Results 
Reads mapping percentages for joint libraries were between 12 ~ 29%, and for serum libraries 
0.03 ~ 0.9%. Between 42 and 53% of the 1555 mouse snoRNA reference sequences were aligned 
with at least one read for joints and 16-26% for serum samples.  
 
The types and expression levels of snoRNAs were identified in ageing and OA joints and serum 
for the first time (Table 1). Table 2 demonstrates the number of DE snoRNA in the different 
contrasts.  
Table 1 
 
Tissue parameters No. snoRNAs expressed 
Young normal joint 1171 
Old normal joint 1286 
DMM joint 1218 
Sham joint 1068 
Young serum 597 
Old serum 646 
DMM serum 591 
Sham serum 498 
 
Table 2 
 
 
Young vs old 
joint 
Young vs old 
serum 
DMM vs 
sham joint 
DMM vs 
sham serum 
Old joint vs 
DMM joint 
Old serum vs 
DMM serum 
Number DE 10 39 5 28 21 79 
 7 8 0 17 1 39 
 3 31 5 11 20 40 
 
 
Conclusions 
 
The number of DE snoRNAs were generally small but greatest in ageing serum samples. A 
number of DE snoRNAs have previously been identified as having roles in oxidative stress, and 
cellular senescence and organismal ageing. Furthermore interesting snoRNA host genes were 
identified including a heparan sulphate sulphotransferase, transforming growth factor β and 
sorting nexin (all with roles in cartilage homeostasis) and Gas-5. Previously the snoRNA host 
gene GAS-5 has been suggested as a mechanism by which ageing and stress effect hippocampal 
function. A recent study identified that a single altered post translational modifications in rRNA 
due to a lack of a specific snoRNA can cause abnormal development and lethality in zebra fish.  
Snord 23 and snora 68 were DE in old vs old DMM joints and previously in our human OA snoRNA 
array studies and represent candidates for further work. Further studies will be undertaken to 
determine the roles for these snoRNAs in ageing and musculoskeletal disease and identify 
possible biomarker candidates.  
 
